SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950127-02-000200
Filing Date
2002-02-13
Accepted
2002-02-13 00:00:00
Documents
1
Group Members
JEFFREY A. RUIZMARGARET M. ADAMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A AMENDMENT NO.2 a854903_13g.txt SC 13G/A 19454
  Complete submission text file 0000950127-02-000200.txt   21279
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 02540376
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

IRS No.: 13294498 | State of Incorp.: I8